Position in ALXO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$277,878
+$258,372 QoQ
Shares Held
138,593
+702.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 68 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. ALXO ranks #308 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in ALXO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $277,878 | 138,593 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,506 | 17,262 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $34,027 | 18,594 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $120,222 | 289,693 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $232,511 | 373,214 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $950,244 | 569,009 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $467,519 | 256,879 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,297,968 | 215,252 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,750,572 | 157,002 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,351,162 | 90,743 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $629,409 | 131,127 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,350,049 | 179,767 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $816,523 | 180,647 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,977,445 | 175,461 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,538,338 | 160,746 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,004,240 | 247,743 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,624,813 | 214,486 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,990,074 | 139,138 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $12,038,883 | 162,996 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,454,687 | 136,333 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $18,684,609 | 253,385 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,346,333 | 131,628 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $278,558 | 7,381 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||